Pages that link to "Q29617899"
Jump to navigation
Jump to search
The following pages link to Cellular processing of platinum anticancer drugs (Q29617899):
Displaying 50 items.
- Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes (Q24289008) (← links)
- The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells (Q24297953) (← links)
- A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity (Q24313389) (← links)
- A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia (Q24338151) (← links)
- Reaction of human metallothionein-3 with cisplatin and transplatin (Q24338731) (← links)
- Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells (Q24596235) (← links)
- Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis (Q24613748) (← links)
- Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile (Q24625759) (← links)
- Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy (Q24629542) (← links)
- Structure-function studies of the RNA polymerase II elongation complex (Q24644966) (← links)
- Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design (Q24646512) (← links)
- Genome-wide requirements for resistance to functionally distinct DNA-damaging agents (Q24815105) (← links)
- Targeting DNA Replication Stress for Cancer Therapy (Q26739923) (← links)
- C-Jun N-terminal kinase signalling pathway in response to cisplatin (Q26745463) (← links)
- New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity (Q26765483) (← links)
- Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature (Q26766244) (← links)
- High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer (Q26774902) (← links)
- Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy (Q26797353) (← links)
- Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer (Q26799484) (← links)
- Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors (Q26852274) (← links)
- Mechanisms of Cisplatin nephrotoxicity (Q26996320) (← links)
- The path for metal complexes to a DNA target (Q26999667) (← links)
- Permeation, regulation and control of expression of TRP channels by trace metal ions (Q26999694) (← links)
- Mitochondrial DNA damage and its consequences for mitochondrial gene expression (Q27001150) (← links)
- Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market (Q27015050) (← links)
- Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta (Q27648988) (← links)
- Mechanism of transcriptional stalling at cisplatin-damaged DNA (Q27648994) (← links)
- Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes (Q27650404) (← links)
- cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects (Q27650949) (← links)
- Crystal Structures of Cisplatin Bound to a Human Copper Chaperone (Q27657700) (← links)
- X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct (Q27661393) (← links)
- Structure of duplex DNA containing the cisplatin 1,2-{Pt(NH3)2}2 -d(GpG) cross-link at 1.77Å resolution (Q27662176) (← links)
- Chemo‐Genetic Optimization of DNA Recognition by Metallodrugs using a Presenter‐Protein Strategy (Q27664742) (← links)
- Consequences of Cisplatin Binding on Nucleosome Structure and Dynamics (Q27666340) (← links)
- Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy (Q27678933) (← links)
- The crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiation (Q27683672) (← links)
- Structural and mechanistic studies of polymerase bypass of phenanthriplatin DNA damage (Q27684330) (← links)
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification (Q27684801) (← links)
- The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme (Q27690763) (← links)
- The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c (Q27697308) (← links)
- Oxaliplatin vs. cisplatin: competition experiments on their binding to lysozyme (Q27700850) (← links)
- Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study (Q27704043) (← links)
- Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis (Q27853047) (← links)
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
- Role of Akt signaling in resistance to DNA-targeted therapy (Q28066950) (← links)
- Renal drug transporters and their significance in drug-drug interactions (Q28071292) (← links)
- Chemoresistance and targeted therapies in ovarian and endometrial cancers (Q28073246) (← links)
- Carbon nanotubes as cancer therapeutic carriers and mediators (Q28074309) (← links)
- Resistance to therapy caused by intragenic deletion in BRCA2 (Q28268169) (← links)
- Expression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patient (Q28386717) (← links)